Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis oil formulations versus placebo for adults with ADHD after failure of conventional treatment
MOH_2022-02-27_008616Phase 2Recruiting
- Sponsor
- Barlev Agricultural Crops
- Start
- Dec 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol, dronabinol, cannabidivarin and cannabigerol in attention deficit hyperactivity disorder (ADHD) (4 arms), sponsored by Barlev Agricultural Crops. Primary endpoints: Change in TOVA performance, Change in Conners Adult ADHD questionnaires and 1 more. Started Dec 2019; status: recruiting.
02
Drugs
cannabidioldronabinolcannabidivarincannabigerol
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on MOH_2022-02-27_008616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-02-27_008616.